search
Back to results

Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery

Primary Purpose

Progressive Infantile Idiopathic Scoliosis

Status
Completed
Phase
Phase 2
Locations
Spain
Study Type
Interventional
Intervention
Ketamine Hydrochloride
Placebo
Remifentanil
Morphine hydrochloride
Sponsored by
Fundació Sant Joan de Déu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Progressive Infantile Idiopathic Scoliosis

Eligibility Criteria

8 Years - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients of both genders diagnosed with idiopathic scoliosis aged between 8 and 18 years old.
  2. Patients of both genders diagnosed with idiopathic scoliosis and candidates for vertebral fusion corrective surgery with instrumentation.
  3. Patients with ASA 1 or ASA 2.
  4. Patients and/or parents/tutors consent to participate in the clinical trial.

Exclusion Criteria:

  1. Patients with chronic preoperative pain.
  2. Patients with addiction to narcotics.
  3. Patients with a history of allergy, contraindication or intolerance to the drugs used.
  4. Patients unable to understand the patient-controlled analgesia system.
  5. Patients with mental disorders.
  6. Reoperated patients.
  7. Patients requiring elective postoperative ventilation.
  8. Pregnant patients.

Sites / Locations

  • Hospital Sant Joan de Déu

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Ketamine Hydrochloride

Placebo

Arm Description

Received a combination of ketamine, remifentanil and morphine hydrochloride established by the following dosage regimen: KETAMINE HYDROCHLORIDE 0,5mg/Kg Intravenous bolus administered during the anesthetic induction, followed by 2 mcg / Kg / min of intravenous infusion during and after surgery until 72 hours postoperation during surgery remifentanil 0,3 mcg / kg / min. at the end of the operation morphine hydrochloride150 mcg / kg, PCA infusion postoperatively.

Received a combination of physiological serum, remifentanil and morphine hydrochloride established by the following dosage regimen: 0,9 % physiological serum 0,5mg/Kg administered by an intravenous (IV) line during the anesthetic induction, followed by 2 mcg / Kg / min of intravenous infusion during and after surgery until 72 hours postoperation during surgery remifentanil 0.3 mcg / kg / min. at the end of the operation morphine hydrochloride150 mcg / kg, PCA infusion postoperatively.

Outcomes

Primary Outcome Measures

Cumulative Consumption of Epidural Morphine at 72h Postoperatively
For the assessment of the related ketamine analgesic efficacy. Cumulative consumption of epidural morphine administered as loading dose, intraoperatively, of 0,3 mcg/kg/min until the surgery operation and 150mcg/Kg of Morphine hydrochloride 60min before extubation

Secondary Outcome Measures

Change From Baseline in Pain Scores (Visual Analogue Scale)
Pain scores at rest and on cough using a 10cm Visual Analogue Scale(0=no pain, 10=worst possible pain for the analgesic efficacy assessment of the association of Ketamine and opiates
Rates of significant adverse events
To assess the tolerability of the association of ketamine and opiates
Time to oral tolerability
To assess the efficacy of the association of ketamine and opiates, measuring the time needed from the surgery for reaching the oral tolerability
Time to First Postoperative Ambulation
To assess the efficacy of the association of ketamine and opiates, measuring the time needed to being able to walk without assistance within the room or outside the room
Time to postoperative recovery
Post operation period needed for each patient from the end of the surgery until hospital discharge by counting each patient postoperative hospital night admissions
Change From Baseline in Pain by sensorial test using the Voy Frey filament
measure of the area of hyperalgesia of the inflamed skin and the length of the incision after 72 post surgery. The filaments is used to provide a range of forces to the skin of a test subject, in order to find the force at which the subject reacts because the sensation is painful.
Change From Baseline in Pain Scores (Visual Analogue Scale)
Assessment of pain at week 6 and chronic pain after 3 and 6 months post-surgery using the Visual Analogue Scale pain scale
Change From Baseline in neuropathic pain using Douleur Neuropathique en 4 Questions (DN4) questionnaire
The (DN4) questionnaire is a screening tool for neuropathic pain consisting of interview questions (DN4-interview) and physical tests. Two questions (I and II) were based on the interview of the patient and two questions (III and IV) were based on a standardized clinical examination

Full Information

First Posted
September 28, 2015
Last Updated
October 7, 2015
Sponsor
Fundació Sant Joan de Déu
Collaborators
Instituto de Salud Carlos III
search

1. Study Identification

Unique Protocol Identification Number
NCT02571491
Brief Title
Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery
Official Title
Assessment of the Analgesic Efficacy and Tolerability of the Perioperative Association of the Ketamine With Opiates After Posterior Vertebral Fusion Surgery in Children With Idiopathic Scoliosis
Study Type
Interventional

2. Study Status

Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
February 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fundació Sant Joan de Déu
Collaborators
Instituto de Salud Carlos III

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Comparison of the Efficacy of ketamine measuring the total consumption of morphine in pediatric patients with idiopathic scoliosis
Detailed Description
A randomized unicenter clinical trial, parallel, double-blind study, placebo-controlled group. Involve the participation of Pediatric patients, aged between 11 and 18 years, of both genders, diagnosed with idiopathic scoliosis and posterior spinal fusion surgery candidates included in the Anesthesia Physical Classification System (ASA) 1 or 2 classes. Both groups received remifentanil at doses of 0.3 mcg / Kg / min before surgical procedure and a bolus of 150 mcg / Kg of morphine hydrochloride, approximately 60 minutes before extubation, followed by PCA morphine hydrochloride administration. The patients in the experimental group are treated with a combination of ketamine, remifentanil hydrochloride and morphine while the control group will be treated with a combination of saline, remifentanil and morphine hydrochloride. Treatment of patients in the study is initiated during the induction of anesthesia and ends at the hospital discharge. The total duration of patient participation in the study is 6 months. During treatment the patients being admitted are monitored at regular intervals, at week 6, after the 3rd month and at 6 months post-intervention to assess the incidence of chronic pain. The entire study duration is approximately 24 months. The hypothesis of the study is that the combination of subanesthetic doses of ketamine to opioid drugs during the perioperative period reduces central sensitization processes, resulting in lower consumption of postoperative morphine with fewer adverse effects, postoperative faster recovery and less incidence of chronic pain. The post-operative analgesia is induced by the use of opioids or other analgesics associated with loco-regional techniques. The technique used in the investigators' center is the patient-controlled analgesia (PCA) with the administration of intravenous opioids. The association of ketamine to opioid treatment could reduce the consumption of these and can be useful in surgery. No clinical trials have been conducted in children with scoliosis, who underwent posterior lumbar fusion surgical procedure, evaluating the efficacy of post-operative association of ketamine to opioid drugs for both intra and post-operative periods.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Progressive Infantile Idiopathic Scoliosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
48 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Ketamine Hydrochloride
Arm Type
Experimental
Arm Description
Received a combination of ketamine, remifentanil and morphine hydrochloride established by the following dosage regimen: KETAMINE HYDROCHLORIDE 0,5mg/Kg Intravenous bolus administered during the anesthetic induction, followed by 2 mcg / Kg / min of intravenous infusion during and after surgery until 72 hours postoperation during surgery remifentanil 0,3 mcg / kg / min. at the end of the operation morphine hydrochloride150 mcg / kg, PCA infusion postoperatively.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Received a combination of physiological serum, remifentanil and morphine hydrochloride established by the following dosage regimen: 0,9 % physiological serum 0,5mg/Kg administered by an intravenous (IV) line during the anesthetic induction, followed by 2 mcg / Kg / min of intravenous infusion during and after surgery until 72 hours postoperation during surgery remifentanil 0.3 mcg / kg / min. at the end of the operation morphine hydrochloride150 mcg / kg, PCA infusion postoperatively.
Intervention Type
Drug
Intervention Name(s)
Ketamine Hydrochloride
Other Intervention Name(s)
KETOLAR 50 mg/ml
Intervention Description
50 mg/ml, IV (in the vein) during surgery operation, followed by IV ketamine hydrocloride perfusion 2mcg/Kg/min before and until 72 hours after operation Number of Cycles: until progression or unacceptable toxicity develops.
Intervention Type
Other
Intervention Name(s)
Placebo
Other Intervention Name(s)
0,9 % physiological serum
Intervention Description
50 mg/ml, IV (in the vein) during surgery operation, followed by IV placebo perfusion 2mcg/Kg/min before and until 72 hours after operation
Intervention Type
Drug
Intervention Name(s)
Remifentanil
Intervention Description
at doses of 0.3 mcg / kg / min during and until the end of the surgical operation
Intervention Type
Drug
Intervention Name(s)
Morphine hydrochloride
Intervention Description
at the dose of 150 mcg / kg, 60 minutes before the extubation procedure and until 72 hours after operation by intravenous infusion
Primary Outcome Measure Information:
Title
Cumulative Consumption of Epidural Morphine at 72h Postoperatively
Description
For the assessment of the related ketamine analgesic efficacy. Cumulative consumption of epidural morphine administered as loading dose, intraoperatively, of 0,3 mcg/kg/min until the surgery operation and 150mcg/Kg of Morphine hydrochloride 60min before extubation
Time Frame
in the first 72 hours postoperatively
Secondary Outcome Measure Information:
Title
Change From Baseline in Pain Scores (Visual Analogue Scale)
Description
Pain scores at rest and on cough using a 10cm Visual Analogue Scale(0=no pain, 10=worst possible pain for the analgesic efficacy assessment of the association of Ketamine and opiates
Time Frame
in the first 72 hours after surgery.
Title
Rates of significant adverse events
Description
To assess the tolerability of the association of ketamine and opiates
Time Frame
every 4 hours from the begin until the end of the surgical operation
Title
Time to oral tolerability
Description
To assess the efficacy of the association of ketamine and opiates, measuring the time needed from the surgery for reaching the oral tolerability
Time Frame
up to 6 months from the end of the surgical operation
Title
Time to First Postoperative Ambulation
Description
To assess the efficacy of the association of ketamine and opiates, measuring the time needed to being able to walk without assistance within the room or outside the room
Time Frame
up to 6 months from the end of the surgical operation
Title
Time to postoperative recovery
Description
Post operation period needed for each patient from the end of the surgery until hospital discharge by counting each patient postoperative hospital night admissions
Time Frame
up to 6 months from the end of the surgical operation
Title
Change From Baseline in Pain by sensorial test using the Voy Frey filament
Description
measure of the area of hyperalgesia of the inflamed skin and the length of the incision after 72 post surgery. The filaments is used to provide a range of forces to the skin of a test subject, in order to find the force at which the subject reacts because the sensation is painful.
Time Frame
in the first 72 hours post surgery
Title
Change From Baseline in Pain Scores (Visual Analogue Scale)
Description
Assessment of pain at week 6 and chronic pain after 3 and 6 months post-surgery using the Visual Analogue Scale pain scale
Time Frame
at week 6 and after 3 and 6 months post surgery.
Title
Change From Baseline in neuropathic pain using Douleur Neuropathique en 4 Questions (DN4) questionnaire
Description
The (DN4) questionnaire is a screening tool for neuropathic pain consisting of interview questions (DN4-interview) and physical tests. Two questions (I and II) were based on the interview of the patient and two questions (III and IV) were based on a standardized clinical examination
Time Frame
at week 6 and after 3 and 6 months post surgery.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients of both genders diagnosed with idiopathic scoliosis aged between 8 and 18 years old. Patients of both genders diagnosed with idiopathic scoliosis and candidates for vertebral fusion corrective surgery with instrumentation. Patients with ASA 1 or ASA 2. Patients and/or parents/tutors consent to participate in the clinical trial. Exclusion Criteria: Patients with chronic preoperative pain. Patients with addiction to narcotics. Patients with a history of allergy, contraindication or intolerance to the drugs used. Patients unable to understand the patient-controlled analgesia system. Patients with mental disorders. Reoperated patients. Patients requiring elective postoperative ventilation. Pregnant patients.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marina Perelló Riera, MD
Organizational Affiliation
Hospital Sant Joan de Déu Servicio de Anestesiología, Reanimación y Tratamiento del Dolor
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Sant Joan de Déu
City
Esplugues de Llobregat
State/Province
Barcelona
ZIP/Postal Code
08950
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
12467992
Citation
Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain. 2002 Dec;100(3):213-217. doi: 10.1016/S0304-3959(02)00422-0. No abstract available.
Results Reference
background
PubMed Identifier
10846153
Citation
Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000 Jun 9;288(5472):1765-9. doi: 10.1126/science.288.5472.1765.
Results Reference
background
PubMed Identifier
14581110
Citation
Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003 Nov;106(1-2):49-57. doi: 10.1016/s0304-3959(03)00276-8.
Results Reference
background
PubMed Identifier
10467917
Citation
Schmid RL, Sandler AN, Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain. 1999 Aug;82(2):111-125. doi: 10.1016/S0304-3959(99)00044-5.
Results Reference
background

Learn more about this trial

Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery

We'll reach out to this number within 24 hrs